ArticleLancet (London, England)2019
JAK inhibitors and alopecia areata.
Article in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Treatment of pediatric alopecia areata: A systematic review.Journal of the American Academy of Dermatology · 2022Pooled it
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.Allergy · 2023Trial
- Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.Allergy · 2022Trial
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata.Journal of nanobiotechnology · 2026Article
- Stem cell-based therapies for alopecia areata: a narrative review.Stem cell research & therapy · 2026Review
- Case Reports of Alopecia Areata Associated With Apical Periodontitis.Case reports in dentistry · 2026Article
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.The Journal of dermatology · 2025Article
- Janus kinase inhibitors for alopecia areata: a review of clinical data.Frontiers in immunology · 2025Review
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.The Journal of dermatology · 2024Article
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.Archives of dermatological research · 2024Observational
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology.International journal of molecular sciences · 2024Review
- Alopecia Areata: Current Treatments and New Directions.American journal of clinical dermatology · 2023Review
- Article
- Recent advances in the genetics of alopecia areata.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2023Article
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata.eLife · 2023Article
- Out-of-Pocket Costs in Alopecia Areata: A Cross-Sectional Study in German-speaking Countries.Acta dermato-venereologica · 2023Article
- The potential of regulatory T cell-based therapies for alopecia areata.Frontiers in immunology · 2023Review
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date.Drugs in context · 2023Review
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata.PNAS nexus · 2023Article
- Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.The British journal of dermatology · 2022Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
30696569What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.